Latest filing published 08 Aug 2012 for Ernexa Therapeutics Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -51.1%Entry US$352,500.00 · Close at T+365 US$172,500.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Christopher Allen George: trading record in brief
Christopher Allen George appears in our data through filings on Ernexa Therapeutics Inc. shares, published by SEC (Form 4). We count 2 filings; the first trade dates from 29 November 2010 and the latest from 6 August 2012.
Every open-market trade on record is a purchase: 1 purchase worth €159, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant.
Most recently, on 8 August 2012, the filings show a share grant in Ernexa Therapeutics Inc. The last purchase on record was published on 12 April 2011, which is 5,690 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher Allen George
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 60,000 shares0Common StockSEC:0001019687-12-002665:0
- 600 shares@ US$0.35Common StockSEC:0001019687-11-001160:0Canonical exit: 27 Feb 2011 (T+90)
2 of 2 declarations
